Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival probability of epigenetically defined IDH-wild-type glioblastoma without necrosis or vascular proliferation.
Harter PN, Weber KJ, Ricklefs FL, Drexler R, Schüller U, Hack M, Hanke T, Dohmen H, Acker T, von Deimling A, Hasselblatt M, Divé I, Unger K, Steinbach JP, Capper D, Ronellenfitsch MW. Harter PN, et al. Among authors: dive i. Neurooncol Adv. 2024 Aug 2;6(1):vdae138. doi: 10.1093/noajnl/vdae138. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 39184173 Free PMC article. No abstract available.
2D 1H sLASER Long-TE and 3D 31P Chemical Shift Imaging at 3 T for Monitoring Fasting-Induced Changes in Brain Tumor Tissue.
Alcicek S, Divé I, Thomas DC, Prinz V, Forster MT, Czabanka M, Weber KJ, Steinbach JP, Ronellenfitsch MW, Hattingen E, Pilatus U, Wenger KJ. Alcicek S, et al. Among authors: dive i. J Magn Reson Imaging. 2025 Jan;61(1):426-438. doi: 10.1002/jmri.29422. Epub 2024 May 9. J Magn Reson Imaging. 2025. PMID: 38722043 Free PMC article.
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastoma.
Divé I, Weber KJ, Hartung TI, Steidl E, Wagner M, Hattingen E, Franz K, Fokas E, Ronellenfitsch MW, Herrlinger U, Harter PN, Steinbach JP. Divé I, et al. Neurooncol Adv. 2023 Oct 17;5(1):vdad131. doi: 10.1093/noajnl/vdad131. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 38024242 Free PMC article.
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.
Eckhardt A, Drexler R, Schoof M, Struve N, Capper D, Jelgersma C, Onken J, Harter PN, Weber KJ, Divé I, Rothkamm K, Hoffer K, Klumpp L, Ganser K, Petersen C, Ricklefs F, Kriegs M, Schüller U. Eckhardt A, et al. Among authors: dive i. Neuro Oncol. 2024 Mar 4;26(3):503-513. doi: 10.1093/neuonc/noad197. Neuro Oncol. 2024. PMID: 37818983 Free PMC article.
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Drexler R, Schüller U, Eckhardt A, Filipski K, Hartung TI, Harter PN, Divé I, Forster MT, Czabanka M, Jelgersma C, Onken J, Vajkoczy P, Capper D, Siewert C, Sauvigny T, Lamszus K, Westphal M, Dührsen L, Ricklefs FL. Drexler R, et al. Among authors: dive i. Neuro Oncol. 2023 Feb 14;25(2):315-325. doi: 10.1093/neuonc/noac177. Neuro Oncol. 2023. PMID: 35868257 Free PMC article.
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW. Luger AL, et al. Among authors: dive i. J Neurooncol. 2022 Sep;159(2):243-259. doi: 10.1007/s11060-022-04049-w. Epub 2022 Jul 21. J Neurooncol. 2022. PMID: 35864412 Free PMC article.
18 results